KATIE SZYMAN
WORLDWIDE PRESIDENT
BD ADVANCED PATIENT MONITORING
WHY: Leads Irvine-based BD Advanced Patient Monitoring, formerly the Critical Care unit of Edwards Lifesciences.
IN THE NEWS: Edwards completed in September the $4.2B sale of the unit to global medtech firm BD.
NOTABLE: The unit is developing a next generation monitoring system to replace the standard blood pressure monitoring cuff with a device that monitors blood pressure at the fingertips called the ClearSight Acumen IQ Finger Cuff.
QUOTABLE: “Together, we will improve the quality of care for more patients with more innovative solutions for our customers globally. The best is yet to come.”
